Citadel Advisors
INMB icon

Citadel Advisors’s INmune Bio INMB Stock Holding History

Citadel Advisors’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-176,100
Closed -$365K – 13332
2025
Q3 		$365K Sell
176,100
-228,800
-57% -$524K ﹤0.01% 9891
2025
Q2 		$935K Buy
404,900
+370,100
+1,064% +$2.72M ﹤0.01% 7252
2025
Q1 		$272K Buy
34,800
+17,000
+96% +$135K ﹤0.01% 9808
2024
Q4 		$83.1K Sell
17,800
-28,600
-62% -$149K ﹤0.01% 11741
2024
Q3 		$250K Buy
46,400
+44,000
+1,833% +$313K ﹤0.01% 9672
2024
Q2 		$21.2K Sell
2,400
-1,100
-31% -$10.8K ﹤0.01% 12583
2024
Q1 		$41.1K Buy
3,500
+1,600
+84% +$19.3K ﹤0.01% 12367
2023
Q4 		$21.4K Sell
1,900
-4,400
-70% -$36.9K ﹤0.01% 12567
2023
Q3 		$43.1K Buy
6,300
+2,600
+70% +$21.6K ﹤0.01% 11921
2023
Q2 		$33.6K Buy
3,700
+1,600
+76% +$12.9K ﹤0.01% 12237
2023
Q1 		$13.6K Sell
2,100
-14,000
-87% -$113K ﹤0.01% 13355
2022
Q4 		$102K Buy
+16,100
New +$114K ﹤0.01% 11188
2022
Q2 		– Sell
-24,700
Closed -$208K – 13459
2022
Q1 		$208K Sell
24,700
-13,500
-35% -$121K ﹤0.01% 11443
2021
Q4 		$390K Sell
38,200
-44,900
-54% -$665K ﹤0.01% 10283
2021
Q3 		$1.61M Buy
83,100
+32,200
+63% +$622K ﹤0.01% 6902
2021
Q2 		$894K Buy
+50,900
New +$686K ﹤0.01% 8650

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors's INMB Position: Q2 2025 in Review

Citadel Advisors sold out of INmune Bio (INMB) in Q2 2025, closing a stake of 101,511 shares — an estimated $745K sold.

Citadel Advisors first reported a position in INMB in Q1 2019 and held it in 17 quarters. The position peaked at $1.02M in Q3 2021. 79 funds tracked by Wall St. Rank hold INMB as of Q2 2025.

  • Citadel Advisors reported no remaining INmune Bio position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 101,511 INmune Bio shares in Q2 2025, an estimated $745K.
  • Citadel Advisors first reported a position in INmune Bio in Q1 2019 and held it in 17 quarters.
  • Citadel Advisors's INmune Bio position peaked at $1.02M in Q3 2021.
  • 79 funds tracked by Wall St. Rank held INmune Bio as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.